Skip to main content
. 2013 Jan 30;3:844. doi: 10.1038/srep00844

Figure 7. Spatial orientation of key interaction residues with regard to test ligands.

Figure 7

(a) (9Z)-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)octadec-9-en-1-one (mint), (b) Guineensine (blue), and (c) Retrofractamide A (violet). Common residues are illustrated by yellow surfaces.